Dmitry Grinko spoke to the Cuban guests about the tasks of the Center. Photo: Ministry of Health of Belarus. 

Havana, February 5 (RHC)-- Dmitry Grinko, director of the Center for Medical Examinations and Expertise -CEPM-, of the Belarusian Ministry of Health, received the visit of Cuban Ambassador to Belarus Juan Valdes, with the aim of presenting Cuban vaccines and deepening the forms of bilateral medical collaboration with respect to another group of medicines and biotechnological products of our country. 

During the meeting, which was also attended by representatives of the Center and the Embassy, cooperation issues were discussed in the field of the use of medicines, as well as medical devices produced in both countries. Dmitry Grinko told the Cuban guests about the tasks of the Center and about the work of international level laboratories with accreditation and prequalification abroad of the World Health Organization. 

Summing up the meeting, the CEPM director noted that "there was an exchange of information on approaches to regulation and rules for registration of drugs and medical devices, including in the conditions of COVID-19. In particular, Cuban colleagues were interested in the registration and management of drugs and medical devices in accordance with national rules and the rules of the Eurasian Economic Union.

One of the main tasks of the healthcare system is to provide affordable and high-quality medical products to the citizens of our country, and I am sure that interaction in these areas will contribute to the mutual saturation of medical products in the markets of both countries."

At the meeting, Juan Valdés Figueroa shared information on advances in vaccine development, including for the prevention of coronavirus infection with the Cuban Abdala and Soberana vaccines, as well as opportunities for the Cuban pharmaceutical industry in general. The Cuban side has given high appreciation to the assortment and quality of medical products produced in our country. At the meeting it was noted that Cuban medicines produced by the CIGB of the Republic of Cuba are already registered in Belarus, they are biotechnological medicines. We are talking about such agents as Leucocim (filgrastim), Heberprot - P (recombinant human epidermal growth factor), EPOCIM (a drug based on recombinant human erythropoietin alpha type).